Clinical trial
Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
NCT06781879 is registered in ClinicalTrials.gov with Jakob Kristian Jakobsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
- Lead sponsor
- Jakob Kristian Jakobsen
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- June 1, 2025
- Completion date
- February 1, 2032
- Enrollment
- 272 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
non-muscle invasive bladder cancer